trade exhibition are listed in Table 12 . Table 12: Most Common Adverse Reactions (>5.0 Percent) in Placebo-Controlled Studies of Metformin Hydrochloride Extended-release Tablets * * Reactions those were more common in Metformin hydrochloride extended-release tablets than placebo-treated patients. Adverse Reaction Metformin Hydrochloride Extended- release Tablets (n=781) Placebo (n=195) % of Patients Diarrhea 9.6 2.6 Nausea/Vomiting 6.5 1.5 Diarrhea led to discontinuation of study medication in 0.6% of patients treated with Metformin hydrochloride extended-release tablets. Additionally occasionally
lots of ommon in Metformin hydrochloride extended-release tablets- than placebo-treated patients the fact
EmoticonEmoticon